# UBS analyst maintained a Buy rating on CSPC Pharmaceutical Group on May 21 and set a price target of HK$10.90.

*biotech · news · 2026-05-23 · Markets Insider*

## Key points

- UBS analyst reaffirmed a Buy rating on CSPC Pharmaceutical Group with a HK$10.90 target.
- CSPC shares closed at HK$7.34, significantly below the UBS target price.
- Analyst consensus rates CSPC as Moderate Buy, with a HK$10.42 price target consensus.
- CSPC's quarterly revenue and net profit both declined year-over-year as of December 31.

**Companies:** CSPC Pharmaceutical Group

[Read the full story on Markets Insider](https://markets.businessinsider.com/news/stocks/cspc-pharmaceutical-group-chjtf-receives-a-buy-from-ubs-1036189889)

---

Canonical: https://newsio.io/n/29b4c7a5-a34a-41b3-8758-83b6fb0920ae/ubs-analyst-maintained-a-buy-rating-on-cspc-pharmaceutical-group-on-may-21-and-s
Summarized by Newsio from Markets Insider. https://newsio.io/how-it-works